(Q21092899)
Statements
1 reference
Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels (English)
1 reference
Eliseo Rondon
1 reference
Ramesh Venkataraman
1 reference
scientific article